StockFin.ai
/
Sign inTry Free

Tools

Search Companies
News & Filings
Insights & Articles
FeaturesComing Soon
Pricing

Platinum Industries Ltd (PLATIND) — FY26 Annual Report | 2 September 2026

· BSE 🔴 High Importance Neutral
By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings
📢 Key Event
Platinum Industries Ltd approved a ₹25 crore loan to Rivadu Lifesciences and ₹800 million transactions with PSEL/POCPL for Egypt expansion, targeting 40% revenue growth by FY27.
🔄 What Changed
Revenue growth of 14.8% YoY to ₹4,504.40 million; PAT up 3.7% to ₹512.30 million; EBITDA margin declined to 13.3%; new 60,000 MT Egypt facility commissioning in FY27; 40% FY27 revenue growth target; ₹25 crore loan approval to Rivadu Lifesciences.
🔮 What's Next
Target revenue growth of ~40% in FY27 (CAGR ~35% from FY26-FY29); commissioning of 60,000 MT capacity facility in Egypt by FY27; expansion into MENA, Europe, South America, and Africa markets; development of eco-friendly calcium-zinc and oleo-based stabilizers; sustainability initiatives including lead-free formulations and zero-discharge operations.
💡 Investor Takeaway
The company is aggressively expanding capacity in Egypt and diversifying into pharmaceuticals, targeting 40% revenue growth by FY27 driven by export expansion and sustainable product innovation, while maintaining a net debt-free position and focusing on high-growth end-markets.

Platinum Industries Ltd (PLATIND) reported a 14.8% YoY revenue increase to ₹4,504.40 million in FY26, driven by PVC stabilizers and CPVC additives, with PAT rising 3.7% to ₹512.30 million. The company commissioned a 60,000 MT Egypt facility in FY27, targeting 40% revenue growth by FY27 (CAGR ~35% FY26-FY29). Key risks include skilled workforce constraints and regulatory changes, while opportunities focus on government sector growth and sustainable product innovation. The Board approved a ₹25 crore loan to Rivadu Lifesciences and ₹800 million transactions with PSEL/POCPL for Egypt expansion, with no dividends recommended.

📄 View Original Announcement (PDF)

📊 Stock Analysis — PLATIND✨ Ask AI About This

About Platinum Industries Ltd (PLATIND)

Chemicals · Chemicals · Listed on BSE

Market Cap: ₹1,137.49 CrP/E: 22.6ROE: 11.4%ROCE: 14.5%

View full PLATIND stock details →

📡 Get AI alerts when PLATIND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track PLATIND — Free

💡 Ask AI about this filing

"What is the expected revenue contribution from the Egypt facility in FY27?""How will the ₹25 crore loan to Rivadu Lifesciences impact profitability?""What is the projected EBITDA margin trajectory from FY26-FY29?"
Ask AI Free →

📊 More PLATIND filings

See all PLATIND filings →

🔥 Also filed on 2 September 2026

WAAREEENERWaaree Energies LtdAnnual ReportPEARLPOLYPearl Polymers LtdAnnual Report544627Purple Wave Infocom LtdAnnual Report544437Marc Loire Fashions LtdAnnual ReportRTNINDIARattanIndia Enterprises LtdAnnual Report544596Safecure Services LtdAnnual Report
View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when PLATIND files new disclosures

Track PLATIND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track PLATIND — Free

Free account · 2 AI queries/day